| Product Code: ETC9613220 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Angioedema Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Angioedema Market - Industry Life Cycle |
3.4 Taiwan Angioedema Market - Porter's Five Forces |
3.5 Taiwan Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Taiwan Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.7 Taiwan Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Taiwan Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 Taiwan Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Taiwan Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Taiwan Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about angioedema among healthcare professionals and patients in Taiwan |
4.2.2 Rising prevalence of angioedema cases in Taiwan |
4.2.3 Technological advancements in diagnostic tools and treatment options for angioedema |
4.3 Market Restraints |
4.3.1 High cost of medications and treatments for angioedema |
4.3.2 Limited access to specialized healthcare facilities for angioedema patients in certain regions of Taiwan |
4.3.3 Lack of standardized treatment guidelines for angioedema management in Taiwan |
5 Taiwan Angioedema Market Trends |
6 Taiwan Angioedema Market, By Types |
6.1 Taiwan Angioedema Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Angioedema Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Taiwan Angioedema Market Revenues & Volume, By Solid Dosage Form, 2021- 2031F |
6.1.4 Taiwan Angioedema Market Revenues & Volume, By Liquid Dosage Form, 2021- 2031F |
6.2 Taiwan Angioedema Market, By Route Of Administration |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Angioedema Market Revenues & Volume, By Parenteral Route, 2021- 2031F |
6.2.3 Taiwan Angioedema Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 Taiwan Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 Taiwan Angioedema Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3 Taiwan Angioedema Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Angioedema Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.3.3 Taiwan Angioedema Market Revenues & Volume, By Idiopathic Angioedema, 2021- 2031F |
6.3.4 Taiwan Angioedema Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.3.5 Taiwan Angioedema Market Revenues & Volume, By Drug-Induced Angioedema, 2021- 2031F |
6.3.6 Taiwan Angioedema Market Revenues & Volume, By Hereditary Angioedema, 2021- 2031F |
6.4 Taiwan Angioedema Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Angioedema Market Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021- 2031F |
6.4.3 Taiwan Angioedema Market Revenues & Volume, By Antihistamine, 2021- 2031F |
6.4.4 Taiwan Angioedema Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.5 Taiwan Angioedema Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.4.6 Taiwan Angioedema Market Revenues & Volume, By Adrenaline Injection, 2021- 2031F |
6.4.7 Taiwan Angioedema Market Revenues & Volume, By Hereditary Angioedema Drug Class, 2021- 2031F |
6.4.8 Taiwan Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.4.9 Taiwan Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.5 Taiwan Angioedema Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Taiwan Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 Taiwan Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 Taiwan Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 Taiwan Angioedema Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 Taiwan Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Taiwan Angioedema Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.6.4 Taiwan Angioedema Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Taiwan Angioedema Market Import-Export Trade Statistics |
7.1 Taiwan Angioedema Market Export to Major Countries |
7.2 Taiwan Angioedema Market Imports from Major Countries |
8 Taiwan Angioedema Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in recognizing and treating angioedema |
8.2 Average time taken for diagnosis and initiation of treatment for angioedema patients |
8.3 Patient satisfaction levels with the quality of care and support provided for angioedema management |
8.4 Percentage of angioedema patients receiving timely and appropriate treatment |
8.5 Rate of adherence to treatment plans among angioedema patients |
9 Taiwan Angioedema Market - Opportunity Assessment |
9.1 Taiwan Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Taiwan Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.3 Taiwan Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Taiwan Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 Taiwan Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 Taiwan Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Taiwan Angioedema Market - Competitive Landscape |
10.1 Taiwan Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here